Bajaj Auto workers' union threatens hunger strike at Akurdi plant in Pune over 'anti-worker activities'
A ‘next generation’ vaccine for malaria has shown success in its first human trial. The phase 1 study saw a strong immune response in 10 healthy volunteers. The vaccine was created by genetically engineering the malaria parasite to make it weaker. Scientist removed the three genes needed for it to successfully infect and cause disease in humans. None of the participants developed malaria symptoms, and showed a strong protective antibody response.
Jan 5, 2017
- Maruti U-turn may put India's plan to ease out diesel vehicles on reverse gear
- Infosys row: Company says not aware of any fresh lawsuit
- Why is Yes Bank board wary of tycoon who wouldn't invest if it was 'No Bank'?
- Trump's December 15 China tariffs threaten a long list of Christmas favourites
- SBI under-reported bad loans by Rs 12,000 crore in FY 19, reveals RBI report